ClearPoint Neuro, Inc.
Data quality: 100%
CLPT
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
$10.38
▲
$0.37
(3.70%)
6 months return
—
Momentum
Neutral
5Y revenue growth
22.72%
Growth
Revenue Growth (5Y)
22.72%
Above sector avg (1.72%)
Revenue (1Y)17.78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-143.41%
Below sector avg (-54.68%)
ROIC-35.42%
Net Margin-69.08%
Op. Margin-65.36%
Safety
Debt / Equity
1.84
Above sector avg (0.30)
Current Ratio6.37
Interest Coverage-10.12
Valuation
PE (TTM|NTM)
-10.46 | -10.65
Below sector avg (-1.50)
P/B Ratio16.83
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 22.72% annually over 5 years — strong growth
Negative free cash flow of -24.45 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.94%
Capital efficient — spends only 1.41% of revenue on capex
Price History
Financial Trends
Analyst Price Target
2 analysts
Buy
+140.8%
upside to target
Current
$10.38
Consensus Target
$25.00
$20.00
Low
$30.00
High
Forecast
Forward P/E
-10.65
Forward EPS
-$0.82
Est. Revenue
63.10 M
Earnings Surprises
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.26
·
Rev Est: 12.00 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -$0.22 | -$0.21 | -$0.21 | -$0.27 | — | — |
| Estimate | -$0.16 | -$0.20 | -$0.20 | -$0.20 | -$0.26 | -$0.26 |
| Surprise | -37.50% | -5.00% | -5.00% | -35.00% | — | — |
Growth
Rev 5Y: 22.72% · Earnings 1Y: N/A
Growth
Rev 5Y: 22.72% · Earnings 1Y: N/A| Revenue Growth (1Y) | 17.78% | Revenue Growth (3Y) | 24.23% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22.72% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -143.41% · Net Margin: -69.08%
Profitability
ROE: -143.41% · Net Margin: -69.08%| Revenue (TTM) | 36.97 M | Net Income (TTM) | -25.54 M |
| ROE | -143.41% | ROA | -41.45% |
| Gross Margin | 61.38% | Operating Margin | -65.36% |
| Net Margin | -69.08% | Free Cash Flow (TTM) | -24.45 M |
| ROIC | -35.42% | FCF Growth (3Y) | N/A |
Safety
D/E: 1.84 · Current: 6.37
Safety
D/E: 1.84 · Current: 6.37| Debt / Equity | 1.84 | Current Ratio | 6.37 |
| Interest Coverage | -10.12 | Asset Turnover | 0.60 |
| Working Capital | 43.28 M | Tangible Book Value | 15.87 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -10.46 · EV/EBITDA: N/A
Valuation
P/E: -10.46 · EV/EBITDA: N/A| P/E Ratio | -10.46 | Forward P/E | -10.65 |
| P/B Ratio | 16.83 | P/S Ratio | 7.23 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 4.23 | Fwd Earnings Yield | N/A |
| FCF Yield | -9.15% | ||
| Market Cap | 267.14 M | Enterprise Value | 258.12 M |
Per Share
EPS: -0.90 · FCF/Share: -0.82
Per Share
EPS: -0.90 · FCF/Share: -0.82| EPS (Diluted TTM) | -0.90 | Revenue / Share | 1.24 |
| FCF / Share | -0.82 | OCF / Share | -0.80 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 95.72% · CapEx/Rev: 1.41%
Efficiency
FCF Conv: 95.72% · CapEx/Rev: 1.41%| CapEx / Revenue | 1.41% | FCF Conversion | 95.72% |
| SBC-Adj. FCF | -32.55 M | Growth Momentum | -4.94 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36.97 M | 31.39 M | 23.96 M | 20.55 M | 16.30 M |
| Net Income | -25.54 M | -18.91 M | -22.09 M | -16.44 M | -14.41 M |
| EPS (Diluted) | -0.90 | -0.70 | -0.90 | -0.68 | — |
| Gross Profit | 22.69 M | 19.12 M | 13.61 M | 13.53 M | 11.29 M |
| Operating Income | -24.16 M | -19.75 M | -22.45 M | -16.33 M | -13.37 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13.90 M | 12.39 M | 11.71 M | 10.89 M | 8.99 M |
| SG&A Expenses | 16.50 M | 12.00 M | 11.76 M | 9.61 M | 8.76 M |
| D&A | 814,000.0 | 980,000.0 | 626,000.0 | 244,000.0 | 159,000.0 |
| Interest Expense | 2.39 M | 872,000.0 | 386,000.0 | 81,000.0 | 973,000.0 |
| Income Tax | 55,000.0 | 12,000.0 | 8,000.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 97.75 M | 39.19 M | 42.66 M | 55.49 M | 65.58 M |
| Total Liabilities | 69.73 M | 13.80 M | 21.49 M | 18.60 M | 16.79 M |
| Shareholders' Equity | 28.02 M | 25.39 M | 21.17 M | 36.89 M | 48.79 M |
| Total Debt | 49.08 M | — | 9.95 M | 9.89 M | 9.84 M |
| Cash & Equivalents | 45.92 M | 20.10 M | 23.14 M | 27.62 M | 54.11 M |
| Current Assets | 63.60 M | 33.36 M | 36.17 M | 51.18 M | 61.89 M |
| Current Liabilities | 10.77 M | 10.35 M | 7.43 M | 6.79 M | 4.75 M |
Peer Comparison
vs Manufacturing sector median (1605 peers)
Compared with similar companies in Manufacturing
Peer Comparison
vs Manufacturing sector median (1605 peers) Compared with similar companies in Manufacturing| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.5 | -1.5 |
| P/B | 16.8 | 1.6 |
| ROE % | -143.4 | -54.7 |
| Net Margin % | -69.1 | -41.5 |
| Rev Growth 5Y % | 22.7 | 1.7 |
| D/E | 1.8 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"CLPT","listing_kind":"stock","pathname":"/stocks/clpt","exchange":"NASDAQ","country":"US"}}